SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-20 |
| Reported value | $313,494,011 |
| Positions | 27 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| X4 Pharmaceuticals Inc | XFOR | COM NEW | $34,771,326 | 7,445,680 |
| EA SERIES TRUST | BOXX | ALPHA ARCH 1-3 | $26,484,353 | 226,188 |
| Compass Pathways Plc | CMPS | SPONSORED ADS | $23,197,284 | 1,639,384 |
| Surrozen Inc | SRZN | COM NEW | $19,990,738 | 770,356 |
| Aclaris Therapeutics Inc | ACRS | COM | $19,386,422 | 3,664,730 |
| Veradermics Inc | MANE | COMMON STOCK | $17,911,743 | 145,695 |
| Veradermics Inc | MANE | COOMON STOCK | $17,911,743 | 145,695 |
| Sionna Therapeutics Inc | SION | COM | $17,338,394 | 394,144 |
| Inhibikase Therapeutics Inc | IKT | COM NEW | $15,516,874 | 7,643,780 |
| Pharvaris NV | PHVS | COM | $13,747,072 | 397,544 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.